Alliance Pharma (LON:APH) Hits New 12-Month High – Here’s What Happened

Alliance Pharma plc (LON:APH) reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as GBX 61.60 ($0.77) and last traded at GBX 61.20 ($0.76), with a volume of 5385101 shares traded. The stock had previously closed at GBX 61.20 ($0.76).

Wall Street Analyst Weigh In

Separately, Berenberg Bank downgraded shares of Alliance Pharma to a “hold” rating and lowered their price objective for the company from GBX 7,000 ($86.93) to GBX 6,250 ($77.62) in a research report on Wednesday.

Alliance Pharma Price Performance

The company has a debt-to-equity ratio of 47.46, a quick ratio of 1.42 and a current ratio of 2.93. The business has a 50 day moving average price of GBX 50.26 and a 200-day moving average price of GBX 44.25. The company has a market capitalization of £330.83 million, a price-to-earnings ratio of -1,020.00, a P/E/G ratio of 1.04 and a beta of 0.67.

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.